COVID-19 CUSTOMER UPDATE – 25.03.20

March 25, 2020



Following on from our client update which was sent out on the 19th of March please see below an additional update following further developments and interventions from the Government aimed at tackling the Coronavirus / COVID-19 Pandemic.

CURRENTLY ALL DIVISIONS WITHIN CAWOOD SCIENTIFIC ARE OPERATING AND UNLESS WE BELIEVE THE SAFETY AND WELL BEING OF OUR STAFF WILL BE COMPROMISED BY STAYING OPEN OR FURTHER DEVELOPMENTS FROM THE GOVERNMENT MEAN WE CANNOT CONTINUE TO OPERATE WE WILL REMAIN SO.

IT IS BUSINESS AS USUAL UNLESS WE NOTIFY YOU OTHERWISE

As indicated in our update of the 19th of March we have adopted a three-stage approach to our planning which can be summarised as Prevention, Restriction, and Continuity.  Please see below further actions that we have implemented since our latest update to hopefully minimise the impact of this virus which is affecting our lives.

Prevention

All staff wear gloves when handling sample packaging when received on site in order to minimise the potential for staff to come into contact with the virus should it be present on any packaging we receive.

Restriction

All staff that can carryout their function within the business remotely are doing so and all visits to or travel to sites within the group have been stopped. The only non Cawood staff that will be allowed on site are those employees of the companies supplying key services to the group such as delivery of samples and consumables.

We have minimised staff movement as much as possible between the labs, offices and communal spaces at each of the laboratory divisions in an effort to reduce or eradicate direct contact between staff and are further reducing this by the following:-

We have split our lab teams into separate shifts so we ensure we will have capability to undertake all key tests should one of these teams become infected.

We are looking at the movement of samples between buildings on site and how that can be minimised further.

We have instigated a specific break time, reduced to one a day, for each team to essentially result in each team self isolating within their team.

Continuity

As we stand today as I write this note we are not experiencing any significant problems so far in terms of resource in the lab which is down to the flexibility of our staff and the changes we have made to the day to day operations

As before we are undertaking daily risk assessments for all of our technical laboratories and are developing plans for these most at risk of continuity problems should widespread Coronavirus / COVID-19 infections occur.

We have, as mentioned, increased shift working and continue to employ a 7-day working week where required.

As mentioned in the previous update it is likely that turnaround times will be affected within our divisions and indeed within those companies we utilise to provide us with third party analyses or services.

Let me assure you that we will endeavour to ensure all samples are analysed within the turnaround time you expect but if extreme circumstances force us into a backlog situation,  priority will be given to samples which are taken for regulatory purposes or which are perishable or have a short stability time.

I would like to ask for your understanding in what is an unprecedented challenge for all businesses and may I take this opportunity to thank you for your continued support.

As we are all aware the situation is continuing to develop and consequently we will keep our plans under constant review.  We will post further updates should our plans change in the future.

We hope that this provides you with some reassurance that Cawood Scientific is taking the necessary steps to ensure a continuity of service but if you require any further information please contact us in the usual manner.

 

Nigel Patrick

Group Managing Director Cawood Scientific Ltd